Revolution Medicines, Inc. SEC filings RVMDW
Revolution Medicines, Inc. has 862 filings in SEC EDGAR's recent list, going back to Dec 21, 2016. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
New debt, Other events
|
Oct 13, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 1, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Other events
|
Aug 26, 2026 | Aug 26, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Apr 17, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Other events
|
Apr 16, 2026 | Apr 14, 2026 |
| 424B5 | Prospectus supplement | Apr 15, 2026 | — |
| 424B5 | Prospectus supplement | Apr 15, 2026 | — |
| 305B2 | Filing | Apr 15, 2026 | — |
| FWP | Free writing prospectus | Apr 15, 2026 | — |
| 424B5 | Prospectus supplement | Apr 13, 2026 | — |
| 424B5 | Prospectus supplement | Apr 13, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 13, 2026 | Apr 13, 2026 |
| 424B5 | Prospectus supplement | Feb 25, 2026 | — |
| S-8 | Employee stock plan registration | Feb 25, 2026 | — |
| 10-K | Annual report | Feb 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2026 | Feb 25, 2026 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Other events
|
Oct 17, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jun 24, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2025 | Jun 18, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 26, 2025 |
| S-8 | Employee stock plan registration | Feb 26, 2025 | — |
| 10-K | Annual report | Feb 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Other events
|
Dec 5, 2024 | Dec 3, 2024 |
| 424B5 | Prospectus supplement | Dec 5, 2024 | — |
| FWP | Free writing prospectus | Dec 4, 2024 | — |
| 424B5 | Prospectus supplement | Dec 2, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 2, 2024 | Dec 2, 2024 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Other events
|
Oct 25, 2024 | Oct 25, 2024 |
| 8-K |
Current report
Other events
|
Oct 23, 2024 | Oct 23, 2024 |
| 424B5 | Prospectus supplement | Aug 7, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 7, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2024 | Jun 20, 2024 |
| S-3ASR | Automatic shelf registration | May 8, 2024 | — |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| UPLOAD | Letter from the SEC | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Apr 25, 2024 |
| CORRESP | Letter to the SEC | Apr 19, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2024 | — |
| S-3ASR | Automatic shelf registration | Mar 4, 2024 | — |
| S-8 | Employee stock plan registration | Feb 26, 2024 | — |
| 10-K | Annual report | Feb 26, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2024 | Jan 9, 2024 |
| 8-K/A | Amended current report | Dec 26, 2023 | Nov 8, 2023 |
| CERT | Filing | Nov 16, 2023 | — |
| 8-A12B | Filing | Nov 15, 2023 | — |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Nov 9, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| DEFA14A | Additional proxy material | Nov 1, 2023 | — |
| 425 | Filing | Nov 1, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 1, 2023 | Nov 1, 2023 |
| 425 | Filing | Oct 23, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2023 | Oct 22, 2023 |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Oct 13, 2023 |
| EFFECT | Filing | Sep 29, 2023 | — |
| DEFM14A | Filing | Sep 29, 2023 | — |
| 424B3 | Prospectus | Sep 29, 2023 | — |
| S-4/A | Filing | Sep 27, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2023 | — |
| S-4 | Registration for a merger or exchange | Sep 13, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Sep 5, 2023 | Aug 31, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 425 | Filing | Aug 1, 2023 | — |
| 425 | Filing | Aug 1, 2023 | — |
| 425 | Filing | Aug 1, 2023 | — |
| 425 | Filing | Aug 1, 2023 | — |
| 425 | Filing | Aug 1, 2023 | — |
| 425 | Filing | Aug 1, 2023 | — |
| 425 | Filing | Aug 1, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Aug 1, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 8, 2023 |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| ARS | Annual report to shareholders | Apr 26, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2023 | — |
| DEF 14A | Proxy statement | Apr 26, 2023 | — |
| 8-K |
Current report
Other events
|
Mar 7, 2023 | Mar 2, 2023 |
| 424B5 | Prospectus supplement | Mar 3, 2023 | — |
| 424B5 | Prospectus supplement | Mar 1, 2023 | — |
| S-8 | Employee stock plan registration | Feb 27, 2023 | — |
| 10-K | Annual report | Feb 27, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Agreement ended
|
Dec 7, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 10-Q | Quarterly report | Nov 7, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 1, 2022 | Sep 1, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Other events
|
Jul 22, 2022 | Jul 19, 2022 |
| 424B5 | Prospectus supplement | Jul 20, 2022 | — |
| 424B5 | Prospectus supplement | Jul 19, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2022 | Jul 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 10, 2022 | Jun 8, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 16, 2022 |
| S-8 | Employee stock plan registration | Feb 28, 2022 | — |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 11, 2022 | Jan 11, 2022 |
| 424B5 | Prospectus supplement | Nov 10, 2021 | — |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 4, 2021 | Nov 1, 2021 |
| 10-Q | Quarterly report | Aug 11, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2021 | Jun 22, 2021 |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| DEFA14A | Additional proxy material | May 3, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 30, 2021 | Apr 30, 2021 |
| DEFA14A | Additional proxy material | Apr 28, 2021 | — |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 22, 2021 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Mar 8, 2021 | Mar 4, 2021 |
| S-8 | Employee stock plan registration | Mar 2, 2021 | — |
| S-3ASR | Automatic shelf registration | Mar 2, 2021 | — |
| 10-K | Annual report | Mar 2, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2021 | Mar 2, 2021 |
| 424B4 | Prospectus | Feb 5, 2021 | — |
| EFFECT | Filing | Feb 3, 2021 | — |
| S-1MEF | Filing | Feb 3, 2021 | — |
| S-1/A | Amended registration statement | Feb 3, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| S-1 | Registration statement | Feb 1, 2021 | — |
| 8-K |
Current report
Results of operations
|
Feb 1, 2021 | Feb 1, 2021 |
| UPLOAD | Letter from the SEC | Jan 25, 2021 | — |
| DRS | Filing | Jan 21, 2021 | — |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 424B4 | Prospectus | Jul 10, 2020 | — |
| EFFECT | Filing | Jul 8, 2020 | — |
| CORRESP | Letter to the SEC | Jul 6, 2020 | — |
| CORRESP | Letter to the SEC | Jul 6, 2020 | — |
| S-1 | Registration statement | Jul 6, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2020 | Jun 22, 2020 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2020 | Jun 17, 2020 |
| UPLOAD | Letter from the SEC | Jun 15, 2020 | — |
| DRS | Filing | Jun 9, 2020 | — |
| 10-Q | Quarterly report | May 14, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 14, 2020 | May 14, 2020 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Apr 21, 2020 | Apr 17, 2020 |
| 10-K | Annual report | Mar 30, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 20, 2020 | Mar 18, 2020 |
| S-8 | Employee stock plan registration | Feb 18, 2020 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Feb 18, 2020 | Feb 18, 2020 |
| 424B4 | Prospectus | Feb 13, 2020 | — |
| EFFECT | Filing | Feb 12, 2020 | — |
| CERT | Filing | Feb 11, 2020 | — |
| CORRESP | Letter to the SEC | Feb 11, 2020 | — |
| S-1/A | Amended registration statement | Feb 11, 2020 | — |
| CORRESP | Letter to the SEC | Feb 10, 2020 | — |
| CORRESP | Letter to the SEC | Feb 10, 2020 | — |
| 8-A12B | Filing | Feb 6, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2020 | — |
| S-1/A | Amended registration statement | Feb 3, 2020 | — |
| CORRESP | Letter to the SEC | Jan 27, 2020 | — |
| CORRESP | Letter to the SEC | Jan 17, 2020 | — |
| S-1 | Registration statement | Jan 17, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2020 | — |
| DRSLTR | Filing | Jan 10, 2020 | — |
| DRS/A | Filing | Jan 10, 2020 | — |
| D | Filing | Nov 15, 2019 | — |
| SEC STAFF LETTER | Filing | Nov 12, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- RVMD (Nasdaq), RVMDW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1628171
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.